The absence of TRPML1 with low- or high-expressing TRPML2 reduced the OS of GBM patients, whereas high or low TRPML1 expression showed a protective effect by increased the OS in high-expressing TRPML2 GBM patients. Here, MCOLN2 is linked to glioblastoma.